Medications impact different aspects of the quality of life of patients with systemic lupus erythematosus

Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus

(2021) Alvaro Gomez et al.   Frontiers in Medicine

Patient-Reported Outcomes for Quality of Life in SLE: Essential in Clinical Trials and Ready for Routine Care

(2021) Matthew H. Nguyen et al.   Journal of Clinical Medicine

Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study

(2020) Fernando Afrânio Palmeira de Oliveira et al.   LUPUS

Health‐Related Quality of Life Measures in Adult Systemic Lupus Erythematosus

(2020) Zara Izadi   ARTHRITIS CARE & RESEARCH

Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus

(2017) Stephanie G. Nantes et al.   ARTHRITIS CARE & RESEARCH

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

(2017) Megan E. B. Clowse et al.   Arthritis & Rheumatology

Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus

(2016) Kathleen McElhone et al.   ARTHRITIS CARE & RESEARCH

Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE

(2014) H. Devilliers et al.   RHEUMATOLOGY

Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus

(2014) M. Urowitz et al.   ARTHRITIS CARE & RESEARCH

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials

(2013) Vibeke Strand et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Methods for interpreting change over time in patient-reported outcome measures

(2012) K. W. Wyrwich et al.   QUALITY OF LIFE RESEARCH

Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature

(2012) M. Castelino et al.   RHEUMATOLOGY

Disease-Specific Patient Reported Outcome Tools for Systemic Lupus Erythematosus

(2012) Meenakshi Jolly et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus

(2011) J. G. Hanly et al.   ANNALS OF THE RHEUMATIC DISEASES

Is There an Advantage Over SF-36 with a Quality of Life Measure That Is Specific to Systemic Lupus Erythematosus?

(2011) Z. TOUMA et al.   JOURNAL OF RHEUMATOLOGY

The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE

(2010) B. Griffiths et al.   RHEUMATOLOGY

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus

(2008) C Gordon et al.   ANNALS OF THE RHEUMATIC DISEASES

The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus

(2008) L C Doward et al.   ANNALS OF THE RHEUMATIC DISEASES

Quality of life over time in patients with systemic lupus erythematosus

(2008) Bindee Kuriya et al.   ARTHRITIS AND RHEUMATISM

High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures

(2008) KB Dussán et al.   LUPUS